CompletedPhase 2NCT02039206

The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease

Studying Rare genetic neurological disorder

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Brainsway
Principal Investigator: Carlos Gordon, Prof.
Meir Health Center
Intervention: Deep TMS(device)
Enrollment: 20 enrolled
Eligibility: 20-80 years · All sexes
Timeline: 2014 – 2016

Study locations (1)

Meir Medical Center, Kfar Saba, Israel

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02039206 on ClinicalTrials.gov

← Back to all trials